Skip to Content
Merck
  • Possible roles of the cAMP-mediators EPAC and RAP1 in decidualization of rat uterus.

Possible roles of the cAMP-mediators EPAC and RAP1 in decidualization of rat uterus.

Reproduction (Cambridge, England) (2014-03-04)
Kazuya Kusama, Mikihiro Yoshie, Kazuhiro Tamura, Takiko Daikoku, Tsutomu Takarada, Eiichi Tachikawa
ABSTRACT

The optimal decidualization of endometrial stromal cells (ESCs) following embryo implantation is one of the critical steps to establish pregnancy in rodents and humans. This step is intricately regulated by ovarian hormones. Using in vitro human ESCs model, we previously showed that activation of a cAMP mediator, exchange protein directly activated by cAMP (EPAC), promotes ovarian steroid- or cAMP analog-induced decidualization. However, expressions and functions of EPAC and RAP1 in the uterus during pregnancy have not yet been examined. In this study, we found that the expression of EPAC2 and RAP1 was markedly upregulated in the decidual cells at the implantation sites on days 7 and 9 of pregnancy in rats. Furthermore, both delayed-implantation and artificial decidualization models showed that EPAC2 and RAP1 expression was enhanced in decidual cells. Significant activation of cAMP-responsive element-binding protein (CREB), a central transcriptional factor of cAMP signaling, was observed in decidual cells. These spatiotemporal expressions of protein related EPAC pathway are overlapped by sites with activated cAMP signaling, indicating the association of EPAC signaling with decidualization. Strikingly, further studies in in vitro rat decidualization model showed that the cAMP analog and medroxyprogesterone stimulated the expression of decidual markers, while knockdown of EPAC1/2 and RAP1 attenuated the expressions of these markers. Together, these findings suggest that EPAC and RAP1 are the crucial factors for endometrial decidualization in rat pregnancy.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Adenosine 3′,5′-cyclic monophosphate tris salt, ≥97% (HPLC), powder
Sigma-Aldrich
Adenosine 3′,5′-cyclic monophosphate, ≥98.5% (HPLC), powder
Medroxyprogesterone acetate for peak identification, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
MISSION® esiRNA, targeting human RAPGEF3
Medroxyprogesterone acetate for system suitability, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
MISSION® esiRNA, targeting human RAP1A
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Rapgef4
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Rapgef3
Medroxyprogesterone acetate, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
MISSION® esiRNA, targeting human RAPGEF4
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Rap1a
Sigma-Aldrich
MISSION® esiRNA, targeting human TERF2IP
USP
Medroxyprogesterone acetate, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Medroxyprogesterone 17-acetate, ≥97% (HPLC)
Sigma-Aldrich
Monoclonal Anti-β-Actin antibody produced in mouse, clone AC-15, ascites fluid
Supelco
Medroxyprogesterone 17-acetate, VETRANAL®, analytical standard